Galectin Therapeutics Inc. (GALT) analyst actions
Rating and price-target actions on GALT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the GALT overview →
1 measured GALT analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Galectin Therapeutics Inc. (GALT) And Encourages Shareholders to Reach Out | Press release | +0.81% | +2.69% |
Keep exploring
More GALT: earnings → · SEC filings → · GALT overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | 310 | -0.19% | 41% |
| SI-BONE, Inc. (SIBN) | 310 | +0.14% | 56% |
| MENLO THERAPEUTICS INC COMMON (MNLO) | 308 | 0.00% | 49% |
| Syros Pharmaceuticals, Inc. (SYRS) | 307 | +0.51% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.